← SynDRA
MYRISTIC ACID
SynDRA canonical compound SYN0004058 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Mechanism of action | dna alkylating drug | DNA synthesis inhibitor |
|---|
| Indication | hepatic cancer | hepatocellular carcinoma (HCC) |
|---|
| Disease area | oncology | Oncology |
|---|
All known targets
- ABL1
- CALM
- FFAR1
- FFAR4
- FKBP1A
- HIV nef
- HNF4A
- LY96
- Pseudo lpxC
- RCVRN
- TLR4
- Viru POL
Mechanisms of action (all sources)
- FFAR1 FULL AGONIST
- FFAR4 FULL AGONIST
- HIV nef INHIBITOR
- ABL1 INHIBITOR
- Pseudo lpxC INHIBITOR
- HNF4A INHIBITOR
- TLR4 INHIBITOR
- RCVRN INHIBITOR
- Viru POL INHIBITOR
- LY96 INHIBITOR
- FKBP1A INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- PPARD
- TLR2
- GPR84
- HDAC11
- PPARA
- RAPGEF3
- USP1
- UGT1A8
- UGT1A10
- TRPA1
- TDP1
- TARDBP
- SMPD1
- SIRT6
- ALOX15B
- PPARG
- CBX1
- PLK1
- NR1H4
- KAT2A
- GMNN
- GLP1R
- FEN1
- DNM1
- CYP19A1
- VDR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- Myristate
- N-tetradecan-1-oic acid
- N-tetradecanoic acid
- FEMA NO. 2764
- NSC-5028
- PHILACID-1400
- PRIFRAC-2942
- Tetradecanoic acid
- n-Tetradecanoic acid
- n-Tetradecoic acid
- Crodacid
- n-Tetradecan-1-oic acid
- 1-Tridecanecarboxylic acid
- Univol U 316S
- Hydrofol acid 1495
- Emery 655
- Myristinsaeure
- tetradecoic acid
- Hystrene 9014
- Neo-fat 14
- Myristic acid (natural)
- C14 fatty acid
- Myristic acid, pure
- n-Myristic acid
- Tetradecanoate
- acide tetradecanoique
- NSC 5028
- FEMA No. 2764
- CCRIS 4724
- CH3-[CH2]12-COOH
- HSDB 5686
- UNII-0I3V7S25AW
- Philacid 1400
- CHEBI:28875
- AI3-15381
- Prifac 2942
- C14:0
- EINECS 208-875-2
Look up MYRISTIC ACID in the interactive SynDRA portal →